Antibody-drug conjugate (ADC) platform for cancer
Nanoparticle platform technology for cancer
Advancing novel, orally bioavailable epigenetic modulators for the targeted treatment of cancer
Solutions for discovery, development and manufacture of novel nanoparticles for use as medicines and in medical research
Diagnostic for early and rapid diagnosis and stratification of patients likely to develop severe sepsis and organ failure
Novel technology for bone health
Novel technology to prevent hypoglycemia in diabetics
Novel polymer to replace glucose in peritoneal dialysis fluid therapy
